Genovate Biotechnology Co., Ltd. (4130)
Market Closed
15 Jun, 05:30
TWSE 
XSAU Primary TWSE NT$
25. 70
-0.1
-0.3876%
NT$
- Market Cap
- P/E Ratio
- Div Yield
65,274 Volume
- Eps
NT$ 25.8
Previous Close Want to track 4130 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Genovate Biotechnology Co., Ltd. (4130) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.58B
Trailing P/E (ttm) -353.5
Forward P/E -
PEG ratio 2.58
Price/Sales (ttm) 6.22
Price/Book (mrq) 1.63
Enterprise Value/Revenue 5.48
Enterprise Value/EBITDA 97.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 121.91K
Average volume (90 days) 831.29K
Price summary
52-Week low 17.65
52-Week high 38.89
Beta -
50-Day moving average 27.02
200-Day moving average 29.48
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.1
Trailing annual dividend yield 0.0038%
5-Year annual dividend yield -
Payout ratio -1.22
Dividend Date 24 Sep 2025
Ex-Dividend Date 20 Aug 2025
Last split factor 1,020:1,000
Last split Date 20 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.02%
Operating margin -0.04%
Operational effectiveness
Return on assets -0%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.75
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.85
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 12.67%
Book value per share (mrq) 15.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
